UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009794
Receipt number R000011474
Scientific Title Evaluation of immunochromatography test kit in genital chlamydia infections rapid test.
Date of disclosure of the study information 2013/02/01
Last modified on 2016/01/20 10:52:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of immunochromatography test kit in genital chlamydia infections rapid test.

Acronym

Evaluation of rapid diagnostic test.

Scientific Title

Evaluation of immunochromatography test kit in genital chlamydia infections rapid test.

Scientific Title:Acronym

Evaluation of rapid diagnostic test.

Region

Japan


Condition

Condition

Sexually transmitted infections

Classification by specialty

Obstetrics and Gynecology Laboratory medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of immunochromatography test kit in genitalchlamydialinfections

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Compare performance of the new test kit with the traditional one, and evaluate the usefulness in clinical testing.
1)Evaluate the correlation between the new kit and traditional tests.
2)Evaluate the usefulness of the handling and the rapidity.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1)Suffers from sexually transmitted infections.
2)Getting the agreement of the clinical evaluation from patients or her agents.

Key exclusion criteria

1)Typical symptom(i.e. yoghurt like secretion) is appeared clearly and is not need the diagnosis to use the test kit.
2)Patient for whom a clinical followup and a clear final diagnosis are judged to be difficult.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasuhisa Terao

Organization

Juntendo University

Division name

Obstetrics and Gynecology

Zip code


Address

2-1-1 Hongo,Bunkyo Tokyo

TEL

03-3813-3111

Email

yterao@juntendo.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yasuhisa Terao

Organization

Juntendo University

Division name

Obstetrics and Gynecology

Zip code


Address

2-1-1,Hongo,Bunkyo Tokyo

TEL

03-3813-3111

Homepage URL


Email

yterao@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

Juntendo University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kanto Chemical Co.,Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 01 Month 15 Day

Date of IRB


Anticipated trial start date

2013 Year 02 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2015 Year 07 Month 22 Day


Other

Other related information

Compare the new test kit with traditional one, the former should be rapid than latter, and correlate with the latter.


Management information

Registered date

2013 Year 01 Month 17 Day

Last modified on

2016 Year 01 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011474